EDN1 and glomerulosclerosis: The role of ET-1 promotes glomerulosclerosis is mediated by EDNRB; the administration of BQ-788, EDNRB antagonist, showed downregulation of the ET-1-induced calcium transient pathway that leads to podocyte detachment [65].